Xenon Pharmaceuticals Inc. (XENE) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $7.50M | — |
| 2024 | $0 | — |
| 2023 | $0 | -100.0% |
| 2022 | $9.43M | -48.8% |
| 2021 | $18.44M | -42.7% |
| 2020 | $32.17M | +371.0% |
| 2019 | $6.83M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $7.50M | — |
| 2024 | $0 | — |
| 2023 | $0 | -100.0% |
| 2022 | $9.43M | -48.8% |
| 2021 | $18.44M | -42.7% |
| 2020 | $32.17M | +371.0% |
| 2019 | $6.83M | — |